AUG 21, 2018 08:52 PM PDT

New Drug Delivery System for Precision Medicine

WRITTEN BY: Nouran Amin

A flexible drug delivery device providing controlled released offers the latest in personalized medicine. The device was developed by The Korea Advanced Institute of Science and Technology (KAIST) and offers a path to theragnosis.

An emerging medical technology, theragnosis, is receiving popularity as a key factor in advancing precision medicine by featuring simultaneous diagnosis and therapeutics. Theragnosis devices include smart contact lenses and microneedle patches that include physiological data sensors and drug delivery devices. The drug delivery systems are rooted for due to few side-effects, reliable therapeutic results, and minimal dosages in comparison to oral administration. In-human applications were recently conducted by some research groups for osteoporosis treatment research however, these applications have failed to demonstrate successful controlled release drug release through flexible drug delivery systems. Fortunately, for this microdevice, the research team guided under Professor Daesoo Kim from the Department of Biological Science and Professor Keon Jae Lee from the Department of Materials Science and Engineering created a device on a rigid substrate and transferred to an active drug delivery layer to the flexible substrate through an inorganic laser lift-off.

The developed device provided mechanical flexibility while maintaining the ability of precise administration for exact dosages at indicated times. The primary point of the device is to produce a gold cap layer that is directly placed on top of the microreservoir with the drugs inside; this had been seen as impossible in conventional microfabrication. Now, the drug delivery system can be applied to smart contact lenses or brain disease treatments by placing them into cramped and corrugated organs. Additionally, through wireless powering, the drug delivery device will represent a new platform for personalized medicine.

Experiments on animal models showed researchers that treating brain epilepsy was progressing well by releasing anti-epileptic medication through the drug delivery system. The team already proved through animal experimentation that treatment for brain epilepsy made progress by releasing anti-epileptic medication through the microdevice. This will further advance the applications of smart contact lenses, seeking effective therapeutic treatments for brain disease, and subcutaneous implantations during daily healthcare system use.

Source: Korea Advanced Institute of Science and Technology

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 17, 2018
Drug Discovery
JUL 17, 2018
Hunger Hormones for Addiction Treatment?
Hunger hormones, or gut hormones, work to signal the body's state of hunger and fullness. These hormones could potentially serve as a key new treatment...
JUL 24, 2018
Drug Discovery
JUL 24, 2018
The Chili Pepper Drug Aims To Combat Obesity
A new drug was recently developed based on capsaicin, the compound found in chili peppers that is responsible for their spicy properties, was seen to cause...
JUL 28, 2018
Videos
JUL 28, 2018
23andMe Announces Partnership with Drug Company GSK
The collaboration aims to improve personalized therapeutics....
AUG 15, 2018
Drug Discovery
AUG 15, 2018
Experimental Drug May Treat The Chronic Itch
Investigators at the University of Zurich have discovered a new approach that treats the chronic itch thanks to two receptors in the spinal cord and the ri...
SEP 24, 2018
Drug Discovery
SEP 24, 2018
Further Challenges in Alzheimer Drug Development
Scientists at Trinity College Dublin performed a large-scale international study involving the treatment of Alzheimer's disease, which was published in...
NOV 08, 2018
Health & Medicine
NOV 08, 2018
Is Daily Aspirin Safe For Heart Attack Prevention
The benefits of aspirin use in patients with known cardiovascular disease (CVD) are well-established. A 2015 meta-analysis reviewed data gathered from 118,...
Loading Comments...